ClinicalTrials.Veeva

Menu

Regional Anesthesia of Cesarean Section

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Anesthesia, Obestetric

Treatments

Device: spinal needle

Study type

Interventional

Funder types

Other

Identifiers

NCT03556267
ATC 2030

Details and patient eligibility

About

Beta trace protein assay is an indicator of post-spinal CSF leak that predicts the degree of post-spinal headache.

Full description

Beta trace protein is specific for CSF only and it is a quantitative analytic test.

Enrollment

90 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-45 years old
  • free medical history.
  • free obstetric history.

Exclusion criteria

  • high risk pregnancy.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 2 patient groups

spinal needle 27 gauqge
Other group
Description:
It is a device used to penetrate the dura to take CSF sample before injecting the drugs used for spinal anesthesia for cesarean section.
Treatment:
Device: spinal needle
spinal needle 25 gauage
Other group
Description:
It is a device used to penetrate the dura to take CSF sample before injecting the drugs used for spinal anesthesia for cesarean section.
Treatment:
Device: spinal needle

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems